Phase I clinical trial demonstrates safety and feasibility of allogenic keratinocyte application for burns, suggesting potential for improved healing.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Farzanbakhsh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: